Phase
Condition
Autism
Asperger's Disorder
Williams Syndrome
Treatment
Transcranial magnetic stimulation
Clinical Study ID
Ages 12-45 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of Autism Spectrum Disorder (ASD), Asperger's or Autism.
Meet criteria for ASD on clinical assessments (ADOS-2 or CARS/BOSA if conductedremotely & ADI-R)
Aged between 12-45 years old
Have a reliable informant who can complete relevant questionnaires
Must have previously not responded or not tolerated 2 treatments.
Exclusion
Exclusion Criteria:
Any contraindications for TMS e.g. history of seizures
Pregnancy
Any current or past history of any physical condition which in the investigator'sopinion might put the subject at risk or interfere with study resultsinterpretation.
Active substance use (<1 week) or intoxication verified by toxicology screen--ofcocaine, amphetamines, benzodiazepines
Showing symptoms of withdrawal from alcohol or benzodiazepines
DSM-5 diagnosis of bipolar disorder or a psychotic disorder e.g. schizophrenia.
Significant sensory impairments such as blindness or deafness.
Any other indication the PI feels would comprise data
Current severe insomnia (must sleep a minimum of 4 hours the night beforestimulation)
IQ<50 or not testable using IQ measures and no historical IQ score available
Currently taking Clozapine or another medication that the PI determines increasesthe risk of TMS or may disrupt the efficacy.
A motor threshold that is too high to allow safe/tolerable treatment.
Study Design
Connect with a study center
Stanford University
Palo Alto, California 94304
United StatesSite Not Available
Robin Libove
Stanford, California 94305-5719
United StatesSite Not Available
Stanford University
Stanford, California 94305-5719
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.